Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Latest News

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

globenewswire.com
ABSI

EBANX advances emerging market infrastructure with Pakistan expansion in motion and native Apple Pay decryption

globenewswire.com
AAPL

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

globenewswire.com
LSTA

Cadillac Mines Appoints Pierre Beaudoin to Board of Directors

globenewswire.com
CSTL AGNC GFI

SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

globenewswire.com
SLBT

VisionWave Holdings Receives $20 Million Purchase Order for 200 STRATUM VARAN Unmanned Ground Vehicles, Subject to Conditions

globenewswire.com
VWAV

Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma

globenewswire.com
NVCT

Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO

globenewswire.com
QNTM

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

globenewswire.com
TVRD

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

globenewswire.com
ANNX